Correlation Between GeoVax Labs and Immatics Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GeoVax Labs and Immatics Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeoVax Labs and Immatics Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeoVax Labs and immatics biotechnologies GmbH, you can compare the effects of market volatilities on GeoVax Labs and Immatics Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeoVax Labs with a short position of Immatics Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeoVax Labs and Immatics Biotechnologies.

Diversification Opportunities for GeoVax Labs and Immatics Biotechnologies

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between GeoVax and Immatics is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding GeoVax Labs and immatics biotechnologies GmbH in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immatics Biotechnologies and GeoVax Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeoVax Labs are associated (or correlated) with Immatics Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immatics Biotechnologies has no effect on the direction of GeoVax Labs i.e., GeoVax Labs and Immatics Biotechnologies go up and down completely randomly.

Pair Corralation between GeoVax Labs and Immatics Biotechnologies

Assuming the 90 days horizon GeoVax Labs is expected to generate 0.83 times more return on investment than Immatics Biotechnologies. However, GeoVax Labs is 1.21 times less risky than Immatics Biotechnologies. It trades about -0.05 of its potential returns per unit of risk. immatics biotechnologies GmbH is currently generating about -0.14 per unit of risk. If you would invest  13.00  in GeoVax Labs on December 4, 2024 and sell it today you would lose (8.97) from holding GeoVax Labs or give up 69.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy90.0%
ValuesDaily Returns

GeoVax Labs  vs.  immatics biotechnologies GmbH

 Performance 
       Timeline  
GeoVax Labs 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days GeoVax Labs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Immatics Biotechnologies 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days immatics biotechnologies GmbH has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

GeoVax Labs and Immatics Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GeoVax Labs and Immatics Biotechnologies

The main advantage of trading using opposite GeoVax Labs and Immatics Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeoVax Labs position performs unexpectedly, Immatics Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immatics Biotechnologies will offset losses from the drop in Immatics Biotechnologies' long position.
The idea behind GeoVax Labs and immatics biotechnologies GmbH pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk